SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-021279
Filing Date
2023-05-11
Accepted
2023-05-11 16:19:36
Documents
45
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q mnov-20230331.htm   iXBRL 10-Q 1084211
2 EX-31.1 mnov-ex31_1.htm EX-31 17431
3 EX-31.2 mnov-ex31_2.htm EX-31 18026
4 EX-32.1 mnov-ex32_1.htm EX-32 12747
5 EX-32.2 mnov-ex32_2.htm EX-32 13290
  Complete submission text file 0000950170-23-021279.txt   4066811

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mnov-20230331_pre.xml EX-101.PRE 178006
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mnov-20230331.xsd EX-101.SCH 26539
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mnov-20230331_lab.xml EX-101.LAB 259445
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mnov-20230331_def.xml EX-101.DEF 76778
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mnov-20230331_cal.xml EX-101.CAL 29917
39 EXTRACTED XBRL INSTANCE DOCUMENT mnov-20230331_htm.xml XML 629322
Mailing Address 4275 EXECUTIVE SQUARE SUITE 300 LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE SUITE 300 LA JOLLA CA 92037 858-373-1500
MEDICINOVA INC (Filer) CIK: 0001226616 (see all company filings)

IRS No.: 330927979 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33185 | Film No.: 23911344
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences